Novel Chimeric Antigen Receptor Design Technology for CAR-T Cells Published and Licensed Exclusively to Cellinfinity Bio
WEST HAVEN, Conn. & SAN FRANCISCO--(BUSINESS WIRE)--Jul 27, 2023--
Stay updated with breaking news from Cellinfinity Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
WEST HAVEN, Conn. & SAN FRANCISCO--(BUSINESS WIRE)--Jul 27, 2023--
WEST HAVEN, Conn. & SAN FRANCISCO--(BUSINESS WIRE)--Jul 10, 2023--
MAJESTIC technology allows CRISPR-independent, DNA-free and non-lentiviral gene delivery into diverse cell types with high efficiency and cell viabilityCellinfinity has exclusively licensed the technology for development of next-generation genetically enhanced cell therapyWEST HAVEN, Conn. & SAN FRANCISCO--(BUSINESS...
/PRNewswire/ -- Astellas Venture Management LLC (President: William Watt, Ph.D., "AVM"), a wholly-owned venture capital subsidiary of Astellas Pharma Inc....
/PRNewswire/ -- Astellas Venture Management LLC (President: William Watt, Ph.D., "AVM"), a wholly-owned venture capital subsidiary of Astellas Pharma Inc....